Inflammation Reduction Pack
Product Images NDC 69176-010

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Inflammation Reduction Pack (NDC 69176-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tmig, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

E766b73-197d-485a-8933-496bd8353fed (0e766b73 197d 485a 8933 496bd8353fed)

This is a description of a Lidocaine and Prilocaine XY Cream, used only for topical use. It comes in a gram tube and its package has all the necessary information about the cream. The cream contains Lidocaine (25%) and Prilocaine (3.5%) as active ingredients. The tube has a cap that must be turned and pushed for opening and closing. Each gram of the cream contains 25 mg of Lidocaine and Prilocaine along with other ingredients such as polyethylene fatty acid ester, carboxypolymethylene, purified water, and sodium hydroxide. The manufacturer is Actavis Pharma.*

FDA Label Image

A852683-87ab-48de-9e58-372c1d7dbc53 (1a852683 87ab 48de 9e58 372c1d7dbc53)

Diclofenac Sodium is a medication that comes in a delayed-release enteric-coated tablet form with a strength of 75mg. Each tablet must be dispensed in a tightly sealed, light-resistant container. The usual dosage can be found in the accompanying prescription information. It is manufactured by Actavis in Elizabeth, USA and must be stored at a temperature of 25°C (77°F), protected from moisture. The Noc number is 0228255106.*

FDA Label Image

B9de085-17a5-4f2c-bced-05aa8f128cfb (2b9de085 17a5 4f2c Bced 05aa8f128cfb)

This is a medication label for NDC 69176-010-04. The label has a warning to keep the medication out of the reach of children and should be stored at a temperature range of 20-25 degrees Celsius (68-77F) to avoid direct sunlight and excessive moisture. The enclosed leaflets are intended for patients and the medication is copyrighted by T T™IG Inc in 2015.*

FDA Label Image

67617d1-45b1-4361-9e80-85ea3a35f16c (367617d1 45b1 4361 9e80 85ea3a35f16c)

NDC 0591-2070-30 Lidocaine and Prilocaine PXZY Cream is a prescription medication meant for topical use only. The product has 25 mg of lidocaine, 25 mg of prilocaine, polyoxyethylene fatty-acid ester, carboxypolymethylene, purified water, and sodium hydroxide. The pH of the product is 9, and it contains no preservatives. It is advised to read the package insert before applying it to intact skin. The product should be stored at a temperature of 20°C to 25°C. The product is manufactured by GL Laboratories, Inc. and distributed by Actavis Pharma, Inc. To open or close the cover, turn it as instructed on the label.*

FDA Label Image

2936054-43b2-488a-9e14-76bad439bf50 (42936054 43b2 488a 9e14 76bad439bf50)

FDA Label Image

98366de-486f-40d8-9564-6663d33da29d (498366de 486f 40d8 9564 6663d33da29d)

FDA Label Image

0203c33-1b03-448e-800c-51155b8ea7af (60203c33 1b03 448e 800c 51155b8ea7af)

FDA Label Image

4de2c05-43d5-4094-a5e6-80fdf779fb94 (64de2c05 43d5 4094 A5e6 80fdf779fb94)

FDA Label Image

1532690-3c61-4f7f-a496-110f26dc2954 (A1532690 3c61 4f7f A496 110f26dc2954)

FDA Label Image

470f175-8503-4394-a2f0-d388446d11f4 (C470f175 8503 4394 A2f0 D388446d11f4)

FDA Label Image

Bb11ead-e05b-4eef-b02b-81bde5ce8924 (Ebb11ead E05b 4eef B02b 81bde5ce8924)

FDA Label Image

B337713-eb55-4e83-ae93-bee5a14c8cb5 (Fb337713 Eb55 4e83 Ae93 Bee5a14c8cb5)

This is a description of pharmaceutical tablets manufactured by Glenmark. They are 150mg Ranitidine tablets packaged in a 100 count bottle. The tablets are for prescription use only and are labeled with the National Drug Code (NDC) 68462-248-01. There are additional characters in the text that are not readable.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.